BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 17913308)

  • 1. A Yersinia pestis lpxM-mutant live vaccine induces enhanced immunity against bubonic plague in mice and guinea pigs.
    Feodorova VA; Pan'kina LN; Savostina EP; Sayapina LV; Motin VL; Dentovskaya SV; Shaikhutdinova RZ; Ivanov SA; Lindner B; Kondakova AN; Bystrova OV; Kocharova NA; Senchenkova SN; Holst O; Pier GB; Knirel YA; Anisimov AP
    Vaccine; 2007 Nov; 25(44):7620-8. PubMed ID: 17913308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dam mutant of Yersinia pestis is attenuated and induces protection against plague.
    Robinson VL; Oyston PC; Titball RW
    FEMS Microbiol Lett; 2005 Nov; 252(2):251-6. PubMed ID: 16188402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of deletion of the lpxM gene on virulence and vaccine potential of Yersinia pestis in mice.
    Anisimov AP; Shaikhutdinova RZ; Pan'kina LN; Feodorova VA; Savostina EP; Bystrova OV; Lindner B; Mokrievich AN; Bakhteeva IV; Titareva GM; Dentovskaya SV; Kocharova NA; Senchenkova SN; Holst O; Devdariani ZL; Popov YA; Pier GB; Knirel YA
    J Med Microbiol; 2007 Apr; 56(Pt 4):443-453. PubMed ID: 17374882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of mouse, guinea pig and rabbit models for evaluation of plague subunit vaccine F1+rV270.
    Qi Z; Zhou L; Zhang Q; Ren L; Dai R; Wu B; Wang T; Zhu Z; Yang Y; Cui B; Wang Z; Wang H; Qiu Y; Guo Z; Yang R; Wang X
    Vaccine; 2010 Feb; 28(6):1655-60. PubMed ID: 20079562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Yersinia pestis YscN ATPase mutant functions as a live attenuated vaccine against bubonic plague in mice.
    Bozue J; Cote CK; Webster W; Bassett A; Tobery S; Little S; Swietnicki W
    FEMS Microbiol Lett; 2012 Jul; 332(2):113-21. PubMed ID: 22537022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Yersinia pestis guaBA mutant is attenuated in virulence and provides protection against plague in a mouse model of infection.
    Oyston PC; Mellado-Sanchez G; Pasetti MF; Nataro JP; Titball RW; Atkins HS
    Microb Pathog; 2010 May; 48(5):191-5. PubMed ID: 20096773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response.
    Montminy SW; Khan N; McGrath S; Walkowicz MJ; Sharp F; Conlon JE; Fukase K; Kusumoto S; Sweet C; Miyake K; Akira S; Cotter RJ; Goguen JD; Lien E
    Nat Immunol; 2006 Oct; 7(10):1066-73. PubMed ID: 16980981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleiotropic effects of the lpxM mutation in Yersinia pestis resulting in modification of the biosynthesis of major immunoreactive antigens.
    Feodorova VA; Pan'kina LN; Savostina EP; Kuznetsov OS; Konnov NP; Sayapina LV; Dentovskaya SV; Shaikhutdinova RZ; Ageev SA; Lindner B; Kondakova AN; Bystrova OV; Kocharova NA; Senchenkova SN; Holst O; Pier GB; Knirel YA; Anisimov AP; Motin VL
    Vaccine; 2009 Apr; 27(16):2240-50. PubMed ID: 19428838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yersinia pestis with regulated delayed attenuation as a vaccine candidate to induce protective immunity against plague.
    Sun W; Roland KL; Kuang X; Branger CG; Curtiss R
    Infect Immun; 2010 Mar; 78(3):1304-13. PubMed ID: 20086087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.
    Derbise A; Hanada Y; Khalifé M; Carniel E; Demeure CE
    PLoS Negl Trop Dis; 2015; 9(10):e0004162. PubMed ID: 26473734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramuscular Immunization of Mice with a Live-Attenuated Triple Mutant of Yersinia pestis CO92 Induces Robust Humoral and Cell-Mediated Immunity To Completely Protect Animals against Pneumonic Plague.
    Tiner BL; Sha J; Ponnusamy D; Baze WB; Fitts EC; Popov VL; van Lier CJ; Erova TE; Chopra AK
    Clin Vaccine Immunol; 2015 Dec; 22(12):1255-68. PubMed ID: 26446423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of immunization protection efficacy of plague subunit vaccine].
    Zhang QW; Qi ZZ; Xin YQ; Yang YH; Wu HL; Yang HQ; Feng JP; Jin X; Cui BZ; Wang T; Wu BC; Qiu YF; Wang W; Guo ZB; Wang ZY; Yang RF; Wang H; Wang XY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Sep; 43(9):785-8. PubMed ID: 20137561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A live attenuated strain of Yersinia pestis KIM as a vaccine against plague.
    Sun W; Six D; Kuang X; Roland KL; Raetz CR; Curtiss R
    Vaccine; 2011 Apr; 29(16):2986-98. PubMed ID: 21320544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
    Eyles JE; Butcher WA; Titball RW; Hill J
    Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yersinia pestis biovar Microtus strain 201, an avirulent strain to humans, provides protection against bubonic plague in rhesus macaques.
    Zhang Q; Wang Q; Tian G; Qi Z; Zhang X; Wu X; Qiu Y; Bi Y; Yang X; Xin Y; He J; Zhou J; Zeng L; Yang R; Wang X
    Hum Vaccin Immunother; 2014; 10(2):368-77. PubMed ID: 24225642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live-attenuated Yersinia pestis vaccines.
    Wang X; Zhang X; Zhou D; Yang R
    Expert Rev Vaccines; 2013 Jun; 12(6):677-86. PubMed ID: 23750796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A live attenuated strain of Yersinia pestis ΔyscB provides protection against bubonic and pneumonic plagues in mouse model.
    Zhang X; Qi Z; Du Z; Bi Y; Zhang Q; Tan Y; Yang H; Xin Y; Yang R; Wang X
    Vaccine; 2013 May; 31(22):2539-42. PubMed ID: 23588087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge.
    Palin A; Chattopadhyay A; Park S; Delmas G; Suresh R; Senina S; Perlin DS; Rose JK
    Vaccine; 2007 Jan; 25(4):741-50. PubMed ID: 16959385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Live Plague Vaccine Candidates.
    Feodorova VA; Sayapina LV; Motin VL
    Methods Mol Biol; 2016; 1403():487-98. PubMed ID: 27076149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of the immune response to the (F1+V) vaccine in models of bubonic and pneumonic plague.
    Williamson ED; Stagg AJ; Eley SM; Taylor R; Green M; Jones SM; Titball RW
    Vaccine; 2007 Jan; 25(6):1142-8. PubMed ID: 17101198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.